Search Results 131-140 of 6422 for younkin
Duvelisib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as CC-486, cyclophosphamide, ...
Pembrolizumab has been approved for treatment of patients with melanoma but has not been proven to be safe or helpful in patients with pancreatic cancer and is ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Pang M, Zhang W, Hu Z, Weng X. [Detection of rpoB mutations in rifampin-resistant Mycobacterium tuberculosis strains by the reverse dot-blot hybridization ...
This 8-week randomized, open-label evaluation will examine the acute safety and tolerability of 4 different dosing regimens of Acthar to inform dose selection ...
Investigators in the Regenerative Neurosurgery and Neuro-Oncology Lab have cast doubts on commonly used markers to gauge stem cell plasticity.
D., is a neurosurgeon with special interest in malignant brain tumor surgery. His clinical focus includes: Brain tumors including gliomas, glioblastomas and ...
This study will investigate sub-concussions, concussions, and pre-syncopal choking episodes in a number of fighters using King Devick Test (KDT). We will also ...
The purpose of this study is to assess the response of pediatric epilepsy patients to deep brain stimulation. Participation eligibility. Participant eligibility ...
The purpose of this study is to assess the safety, tolerability and effectiveness of LJN452 for the treatment of patients who have primary biliary cholangitis.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The deadline to have twice the impact to advance healthcare research is May 15.